Arcus Biosciences RCUS Balance Sheet (2017-2026)

NYSE RCUS
$18.93 +0.65 (+3.56%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Arcus Biosciences Quarterly Balance Sheet

Periods 39 quarters
Latest Sep 2026

Arcus Biosciences reported total assets of $818.00M and total liabilities of $460.00M for the quarter ended Sep 2026, down 16.0% year over year. This balance sheet covers 39 quarters of results from Mar 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
148.00M549.00M273.00M218.00M206.00M238.00M230.00M184.00M127.00M185.00M156.00M201.00M150.00M192.00M248.00M238.00M222.00M201.00M150.00M151.00M
Short-term InvestmentsInvestments (Current)
351.00M664.75M900.15M831.14M803.00M716.00M700.00M615.00M632.00M810.00M813.00M888.00M828.00M805.00M663.00M593.00M759.00M621.00M552.00M479.00M
Cash & Current Investments
499.00M1,213.75M1,173.15M1,049.14M1,009.00M954.00M930.00M799.00M759.00M995.00M969.00M1,089.00M978.00M997.00M911.00M831.00M981.00M822.00M702.00M630.00M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables
17.33M-715.00M35.83M27.29M14.01M33.00M34.00M52.00M38.00M35.00M28.00M16.00M20.00M15.00M15.00M11.00M11.00M3.00M36.00M18.00M
Receivables
Prepaid Assets
18.00M18.53M15.67M21.63M19.00M28.00M22.00M31.00M34.00M34.00M25.00M22.00M18.00M19.00M20.00M15.00M15.00M19.00M18.00M16.00M
Current Assets
1,262.00M1,264.23M1,227.48M1,101.12M1,067.00M1,015.00M986.00M882.00M831.00M1,064.00M1,022.00M1,127.00M1,016.00M1,031.00M946.00M857.00M1,007.00M844.00M756.00M664.00M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
32.00M33.48M33.42M33.89M35.00M37.00M45.00M50.00M51.00M51.00M49.00M48.00M47.00M46.00M44.00M42.00M40.00M38.00M36.00M33.00M
Long-Term Investments
182.00M128.84M98.33M143.14M129.00M90.00M80.00M151.00M107.00M100.00M40.00M2.00M14.00M8.00M16.00M10.00M29.00M54.00M73.00M64.00M
Other Non-Current Assets
116.00M13.89M13.53M13.60M114.00M112.00M109.00M108.00M106.00M78.00M75.00M75.00M73.00M71.00M69.00M65.00M63.00M61.00M59.00M57.00M
Non-Current Assets
330.00M279.20M249.30M292.71M278.00M239.00M234.00M309.00M264.00M229.00M164.00M125.00M134.00M125.00M129.00M117.00M132.00M153.00M168.00M154.00M
Assets
1,592.00M1,543.43M1,476.77M1,393.82M1,345.00M1,254.00M1,220.00M1,191.00M1,095.00M1,293.00M1,186.00M1,252.00M1,150.00M1,156.00M1,075.00M974.00M1,139.00M997.00M924.00M818.00M
Liabilities
Current Liabilities
Accounts Payables
10.00M18.09M21.98M10.55M20.00M28.00M12.00M17.00M17.00M16.00M15.00M13.00M18.00M22.00M29.00M42.00M42.00M39.00M34.00M44.00M
Payables
10.00M18.09M21.98M10.55M20.00M28.00M12.00M17.00M17.00M16.00M15.00M13.00M18.00M22.00M29.00M42.00M42.00M39.00M34.00M44.00M
Accumulated Expenses
24.18M16.20M14.44M20.53M
Other Accumulated Expenses
54.00M37.65M35.02M39.83M76.00M54.00M65.00M80.00M76.00M64.00M71.00M97.00M123.00M98.00M110.00M141.00M154.00M136.00M145.00M141.00M
Current Taxes
2.00M2.82M0.02M0.02M
Current Deferred Revenue
102.00M89.31M90.12M103.29M97.00M97.00M103.00M103.00M91.00M124.00M113.00M105.00M85.00M72.00M71.00M52.00M35.00M34.00M19.00M14.00M
Total Current Liabilities
166.00M161.25M164.02M177.18M193.00M179.00M180.00M200.00M184.00M204.00M199.00M215.00M226.00M192.00M210.00M235.00M231.00M209.00M198.00M199.00M
Non-Current Liabilities
Non-Current Deferred Revenue
462.00M456.91M429.34M382.58M355.00M330.00M330.00M326.00M307.00M242.00M214.00M289.00M234.00M219.00M60.00M53.00M43.00M45.00M37.00M34.00M
Preferred Stock Liabilities
Operating Leases
116.89M114.82M121.34M119.20M
Other Non-Current Liabilities
122.00M13.87M14.68M16.17M140.00M145.00M144.00M145.00M142.00M140.00M138.00M136.00M157.00M166.00M159.00M152.00M135.00M119.00M124.00M125.00M
Total Non-Current Liabilities
628.00M732.55M715.09M678.66M548.00M509.00M510.00M526.00M491.00M446.00M413.00M551.00M508.00M459.00M367.00M386.00M373.00M354.00M336.00M335.00M
Total Liabilities
750.00M746.43M729.77M694.82M688.00M654.00M654.00M671.00M633.00M586.00M551.00M687.00M665.00M625.00M526.00M538.00M508.00M473.00M460.00M460.00M
Shareholder's Equity
Total Debt
47.00M48.00M48.00M97.00M98.00M99.00M100.00M101.00M102.00M
Common Equity
842.00M797.00M747.00M699.00M657.00M600.00M566.00M520.00M462.00M707.00M635.00M565.00M485.00M531.00M549.00M436.00M631.00M524.00M464.00M358.00M
Liabilities and Shareholders Equity
1,592.00M1,543.43M1,476.77M1,393.82M1,345.00M1,254.00M1,220.00M1,191.00M1,095.00M1,293.00M1,186.00M1,252.00M1,150.00M1,156.00M1,075.00M974.00M1,139.00M997.00M924.00M818.00M
Retained Earnings
-275.00M-343.35M-409.98M-474.90M-542.00M-622.00M-697.00M-768.00M-849.00M-853.00M-946.00M-1,038.00M-1,132.00M-1,244.00M-1,244.00M-1,379.00M-1,485.00M-1,613.00M-1,704.00M-1,832.00M

Arcus Biosciences Balance Sheet API

Pull Arcus Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RCUS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY